Clinical Trials · NCT03279731

Binge Eating Liraglutide Intervention

TerminatedPhase 3Liraglutide (Prohibited)
Phase
Phase 3
Recruitment status
Terminated
Sponsor
Kelly Allison
Enrollment
36
Start date
Sep 2017
Locations
1 site, United States
Primary endpoint
Binge Episodes
View Liraglutide compound reference